Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:activeIngredient |
gptkb:mometasone_furoate
|
| gptkbp:administeredBy |
otolaryngologist
|
| gptkbp:alternativeTo |
sinus surgery
oral steroids |
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:duration |
up to 90 days
|
| gptkbp:form |
bioabsorbable implant
|
| https://www.w3.org/2000/01/rdf-schema#label |
SINUVA sinus implant
|
| gptkbp:implantLocation |
ethmoid sinus
|
| gptkbp:indication |
patients with recurrent nasal polyps
|
| gptkbp:manufacturer |
gptkb:Intersect_ENT
|
| gptkbp:mechanismOfAction |
local corticosteroid release
|
| gptkbp:removes |
yes
|
| gptkbp:routeOfAdministration |
intranasal
|
| gptkbp:usedFor |
treatment of nasal polyps
|
| gptkbp:bfsParent |
gptkb:Intersect_ENT
|
| gptkbp:bfsLayer |
7
|